[HTML][HTML] Cost-effectiveness analysis of oral anticoagulants in stroke prevention among patients with atrial fibrillation in Taiwan
CT Liao, MC Lee, ZC Chen, LJE Ku… - Acta Cardiologica …, 2020 - ncbi.nlm.nih.gov
Background Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
Cost-effectiveness analysis of oral anticoagulants in stroke prevention among patients with atrial fibrillation in Taiwan
C Te Liao, MC Lee, ZC Chen… - Acta …, 2020 - researchoutput.ncku.edu.tw
Background: Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
Cost-Effectiveness Analysis of Oral Anticoagulants in Stroke Prevention among Patients with Atrial Fibrillation in Taiwan
CT Liao, MC Lee, ZC Chen, LJE Ku… - Acta …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
Cost-effectiveness analysis of oral anticoagulants in stroke prevention among patients with atrial fibrillation in Taiwan
CT Liao, MC Lee, ZC Chen, LJE Ku… - Acta Cardiologica …, 2020 - nckur.lib.ncku.edu.tw
Background: Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
Cost-Effectiveness Analysis of Oral Anticoagulants in Stroke Prevention among Patients with Atrial Fibrillation in Taiwan
CT Liao, MC Lee, ZC Chen, LJE Ku, JD Wang… - Acta Cardiologica …, 2020 - ir.cnu.edu.tw
Background: Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
Cost-Effectiveness Analysis of Oral Anticoagulants in Stroke Prevention among Patients with Atrial Fibrillation in Taiwan.
CT Liao, MC Lee, ZC Chen, LE Ku, JD Wang… - Acta Cardiologica …, 2020 - europepmc.org
Background Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
Cost-Effectiveness Analysis of Oral Anticoagulants in Stroke Prevention among Patients with Atrial Fibrillation in Taiwan.
CT Liao, MC Lee, ZC Chen, LE Ku, JD Wang… - Acta Cardiologica …, 2020 - europepmc.org
Background Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …